Unknown

Dataset Information

Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients.


ABSTRACT:

Background and objectives

Statins are less efficacious in reducing cardiovascular disease risk in patients on dialysis than in the general population. Recent experimental data showed that phosphate excess promotes cellular de novo cholesterol synthesis through 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase activation. Whether this mechanism might account for the resistance of patients on dialysis to statins has not yet been explored.

Design, setting, participants, & measurements

In this post hoc analysis, we examined the efficacy of statin treatment according to serum phosphate levels in the patients on dialysis who were participants of the A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiov

SUBMITTER: Massy ZA 

PROVIDER: S-EPMC8993469 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature